| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |